Cite this article
Volume | Year
European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.
Complete response after MAID treatment for advanced primary ovarian angiosarcoma: case report and literature review
P. C. Wu1, C. T. Yue2,3, S. C. Huang4,5,*
1 Department of Chinese Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taipei
2 Department of Pathology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taipei
3 Division of Laboratory Medicine, School of Medicine, Tzu Chi University, Hualien
4 Department of Obstetrics and Gynecology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taipei
5 School of Medicine, Tzu Chi University, Hualien (Taiwan)
Eur. J. Gynaecol. Oncol. 2014, 35(3), 318–321; https://doi.org/10.12892/ejgo23922014
Published: 10 June 2014
The patient presented in this case report was a 45-year-old female, with a Stage IIIA ovarian angiosarcoma combined with mature teratoma, that underwent debulking surgery and achieved complete remission for 11 months after six cycles of MAID chemotherapy (mesna, adriamycin/doxorubicin, ifosfamide, and dacarbazine). Thereafter, she had tumor recurrence with peritoneal seeding and massive pleural effusion; hence she received chemotherapy again. Although she had been undergoing a series of chemotherapies, the tumor continued to progress. Hence, she refused further chemotherapy since September 2012. Unfortunately, she passed away in January 2013 due to severe dyspnea with wide spread tumor progression. She had the longestsurvival period (31 months) and complete remission period than the other advanced primary ovarian angiosarcoma cases ever reported in the literature.